CC
HCAT icon

Centiva Capital’s Health Catalyst HCAT Stock Holding History

Centiva Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,806
Closed -$80.7K – 1789
2025
Q1 		$80.7K Sell
17,806
-16,875
-49% -$89.3K ﹤0.01% 1418
2024
Q4 		$245K Sell
34,681
-5,164
-13% -$41.1K 0.01% 1258
2024
Q3 		$324K Buy
+39,845
New +$288K 0.01% 1528
2024
Q2 		– Sell
-46,379
Closed -$349K – 2256
2024
Q1 		$349K Buy
+46,379
New +$423K 0.02% 1169

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $266M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $299M AUM 27.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return